Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Compound Discovery May Spur Therapies for Autoimmune Conditions
Posted on December 20th, 2017 by Christy J. Wilson in Pharma R&D
People who develop autoimmune often suffer from their effects for the rest of their lives, frustrated by the lack of cure. Though there are various treatments available to help manage some of these conditions, they often don’t work very well and the disease continues to take a major toll on the patient and his or her quality of life.
Fortunately many researchers—in university labs, at biotech start-ups and beyond—are laboring to better understand autoimmune diseases so that they can design more effective therapies. In fact, scientists at the University of Colorado Boulder may have just come upon a breakthrough, as they have recently identified a compound that they believe could lead to revolutionary treatments targeting autoimmune diseases. Find out about their study in Ryan Bushey’s article Novel Compound Could Produce New Autoimmune Therapies, published in Drug Discovery & Development.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Christy J. Wilson
Sr. Director, Pharma and Biotech Segment
Connect on LinkedIn
Follow on Twitter
- Unifying Data Standards to Promote Innovation
- Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle
- How Pharma Can Make the Most of Gene Tech CRISPR
- Chemists Concerned About How Their Field is Viewed
- As The Hive Evolves, More Companies Prepare to Join the Program